NASDAQ:ACB • CA05156X8504
The current stock price of ACB is 3.79 USD. In the past month the price decreased by -12.27%. In the past year, price decreased by -25.69%.
ChartMill assigns a fundamental rating of 2 / 10 to ACB. ACB has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months ACB reported a non-GAAP Earnings per Share(EPS) of -0.66. The EPS decreased by -502.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -11.45% | ||
| ROE | -16.55% | ||
| Debt/Equity | 0.06 |
10 analysts have analysed ACB and the average price target is 6.12 USD. This implies a price increase of 61.58% is expected in the next year compared to the current price of 3.79.
For the next year, analysts expect an EPS growth of -1574.6% and a revenue growth 6.2% for ACB
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 31.05 | 985.228B | ||
| JNJ | JOHNSON & JOHNSON | 21.14 | 593.362B | ||
| MRK | MERCK & CO. INC. | 22.9 | 307.597B | ||
| PFE | PFIZER INC | 9.04 | 154.31B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 10.12 | 125.402B | ||
| ZTS | ZOETIS INC | 18.73 | 56.699B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.75 | 26.207B | ||
| VTRS | VIATRIS INC | 6.35 | 18.503B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 25.23 | 13.107B | ||
| AXSM | AXSOME THERAPEUTICS INC | 207.52 | 8.567B |
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.
AURORA CANNABIS INC
2207 90B Street Sw
Leduc ALBERTA T5J 1Y6 CA
CEO: Terry Booth
Employees: 1101
Phone: 16043625207
Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.
The current stock price of ACB is 3.79 USD. The price increased by 3.84% in the last trading session.
ACB does not pay a dividend.
ACB has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
ACB stock is listed on the Nasdaq exchange.
10 analysts have analysed ACB and the average price target is 6.12 USD. This implies a price increase of 61.58% is expected in the next year compared to the current price of 3.79.
The outstanding short interest for AURORA CANNABIS INC (ACB) is 13.43% of its float.